.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Lidocaine; prilocaine - Generic Drug Details

« Back to Dashboard
Lidocaine; prilocaine is the generic ingredient in three branded drugs marketed by Tolmar, Actavis Labs Ut Inc, Dentsply Pharm, Fougera Pharms, Astrazeneca, and Hi Tech Pharma, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has thirty-two patent family members in twenty-nine countries.

There are twenty-nine drug master file entries for lidocaine; prilocaine. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: lidocaine; prilocaine

Tradenames:3
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list29
Suppliers / Packaging: see list22
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: lidocaine; prilocaine

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tolmar
LIDOCAINE AND PRILOCAINE
lidocaine; prilocaine
CREAM;TOPICAL076320-001Aug 27, 2003RXNo► subscribe► subscribe
Astrazeneca
EMLA
lidocaine; prilocaine
DISC;TOPICAL020962-001Feb 4, 1998DISCNNo► subscribe► subscribe
Dentsply Pharm
ORAQIX
lidocaine; prilocaine
GEL;PERIODONTAL021451-001Dec 19, 2003RXYes6,031,007► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine; prilocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 19924,529,601► subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 19924,562,060► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine; prilocaine

Country Document Number Estimated Expiration
Slovakia169897► subscribe
Brazil9702147► subscribe
Russian Federation2185153► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc